These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37957510)

  • 1. Expanding Access to Immediate Lymphatic Reconstruction Through an Axillary Surgery Referral Program: A 6-Year Single-Center Experience.
    Roldan-Vasquez E; Bharani T; Mitri S; Flores R; Capasso K; Ross J; Singhal D; James TA
    Ann Surg Oncol; 2024 Mar; 31(3):2025-2031. PubMed ID: 37957510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction.
    Guzzo HM; Valente SA; Schwarz GS; ElSherif A; Grobmyer SR; Cakmakoglu C; Djohan R; Bernard S; Lang JE; Pratt D; Al-Hilli Z
    Breast Cancer Res Treat; 2022 Dec; 196(3):657-664. PubMed ID: 36239840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of immediate lymphatic reconstruction on the post-operative drain output after axillary lymph node dissection for breast cancer: A retrospective comparative study.
    Lin YS; Kuan CH; Tsai LW; Wu CH; Huang CH; Yeong EK; Tai HC; Huang CS
    Microsurgery; 2023 Sep; 43(6):555-562. PubMed ID: 36762663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and Feasibility of an Immediate Lymphatic Reconstruction Program in a Community Health System.
    Haravu PN; Shakir A; Jackson K; Alva D; Feldman J; Sisco M; Seth AK
    Ann Surg Oncol; 2024 Jan; 31(1):672-680. PubMed ID: 37938474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06).
    Park Y; Shin YS; Kim K; Shin KH; Chang JH; Kim SS; Jung JH; Park W; Kim H; Kim YB; Ahn SJ; Kim M; Kim JH; Cha HJ; Kim TG; Park HJ; Lee SY
    Eur J Surg Oncol; 2023 Mar; 49(3):589-596. PubMed ID: 36470801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at the Time of Axillary Lymph Node Dissection: Two-Site Prospective Trial.
    Benolken MM; McLaughlin S; Piltin M; Mrdutt M; Li Z; Jakub JW
    Ann Surg Oncol; 2023 Oct; 30(10):6042-6049. PubMed ID: 37466868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center.
    Sargent RE; Siegel E; Ito F; Kramme K; Kraft E; Hendrix V; Carr AA; Nelson ME; Bian SX; Jayachandran P; Sener SF
    J Surg Oncol; 2023 Jul; 128(1):9-15. PubMed ID: 36933187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
    Simons JM; van Nijnatten TJA; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef C; Sars PRA; Heijmans HJ; van Haaren ERM; Vles WJ; Contant CME; Menke-Pluijmers MBE; Smit LHM; Kelder W; Boskamp M; Koppert LB; Luiten EJT; Smidt ML
    JAMA Surg; 2022 Nov; 157(11):991-999. PubMed ID: 36069889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of axillary surgery on outcome of clinically node positive breast cancer treated with neoadjuvant chemotherapy.
    Dux J; Habibi M; Malik H; Jacobs L; Wright PA; Lange J; Camp M; O'Donnell M; Sun B; Tran HT; Euhus D
    Breast Cancer Res Treat; 2023 Nov; 202(2):267-273. PubMed ID: 37531016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating Lymphovenous Anastomosis in Clinically Node-Positive Women Receiving Neoadjuvant Chemotherapy: A Shared Decision-Making Model and Nuanced Approached to the Axilla.
    Lustig DB; Temple-Oberle C; Bouchard-Fortier A; Quan ML
    Curr Oncol; 2023 Apr; 30(4):4041-4051. PubMed ID: 37185419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
    Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative axillary surgery is emerging in the surgical management of breast cancer.
    Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y
    Breast Cancer; 2023 Jan; 30(1):14-22. PubMed ID: 36342647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ultrasound evaluation of the axilla increase the rate of axillary lymph node dissection in early stage clinically node negative breast cancer patients?
    Vasigh M; Meshkati Yazd SM; Karoobi M; Hajebi R; Yazdankhah Kenari A
    BMC Surg; 2022 Mar; 22(1):80. PubMed ID: 35241059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
    Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
    Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?
    Lu X; He M; Yu L; Gou Z
    Cancer; 2023 May; 129(10):1492-1501. PubMed ID: 36807239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis.
    Cocco D; Shah C; Wei W; Wilkerson A; Grobmyer SR; Al-Hilli Z
    Br J Surg; 2022 Nov; 109(12):1293-1299. PubMed ID: 36066266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
    ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
    Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM
    J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
    Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.